ANI Pharmaceuticals, Inc. (ANIP)
74.67
-0.15
(-0.20%)
USD |
NASDAQ |
Mar 20, 16:00
74.70
+0.03
(+0.04%)
After-Hours: 20:00
ANI Pharmaceuticals EPS Diluted (Quarterly) : 1.172 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 0.1493 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Castle Biosciences, Inc. | -0.0795 |
| Liquidia Corp. | 0.1455 |
| Allogene Therapeutics, Inc. | -0.1717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.39M |
| Revenue (Quarterly) | 247.06M |
| Total Expenses (Quarterly) | 221.67M |
| Enterprise Value | 2.007B |
| Gross Profit Margin (Quarterly) | 50.26% |
| Profit Margin (Quarterly) | 10.28% |
| Earnings Yield | 4.49% |
| Operating Earnings Yield | 5.23% |
| Normalized Earnings Yield | 3.003 |